- Home
- NHI vs PCVX Comparison
NHI vs PCVX Comparison
Compare NHI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHI
- PCVX
- Stock Information
- Founded
- NHI 1991
- PCVX 2013
- Country
- NHI United States
- PCVX United States
- Employees
- NHI N/A
- PCVX N/A
- Industry
- NHI Real Estate Investment Trusts
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- NHI Real Estate
- PCVX Health Care
- Exchange
- NHI Nasdaq
- PCVX Nasdaq
- Market Cap
- NHI 3.7B
- PCVX 4.0B
- IPO Year
- NHI 1991
- PCVX 2020
- Fundamental
- Price
- NHI $73.51
- PCVX $43.49
- Analyst Decision
- NHI Buy
- PCVX Strong Buy
- Analyst Count
- NHI 4
- PCVX 8
- Target Price
- NHI $82.75
- PCVX $114.17
- AVG Volume (30 Days)
- NHI 228.5K
- PCVX 2.2M
- Earning Date
- NHI 11-06-2025
- PCVX 11-04-2025
- Dividend Yield
- NHI 5.02%
- PCVX N/A
- EPS Growth
- NHI 6.78
- PCVX N/A
- EPS
- NHI 3.14
- PCVX N/A
- Revenue
- NHI $350,596,000.00
- PCVX N/A
- Revenue This Year
- NHI $5.62
- PCVX N/A
- Revenue Next Year
- NHI $10.34
- PCVX N/A
- P/E Ratio
- NHI $23.37
- PCVX N/A
- Revenue Growth
- NHI 7.21
- PCVX N/A
- 52 Week Low
- NHI $65.13
- PCVX $27.66
- 52 Week High
- NHI $82.32
- PCVX $118.62
- Technical
- Relative Strength Index (RSI)
- NHI 36.16
- PCVX 68.94
- Support Level
- NHI $71.50
- PCVX $42.75
- Resistance Level
- NHI $80.35
- PCVX $45.12
- Average True Range (ATR)
- NHI 1.70
- PCVX 2.10
- MACD
- NHI -0.65
- PCVX 0.41
- Stochastic Oscillator
- NHI 22.71
- PCVX 84.68
About NHI National Health Investors Inc.
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.